We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Pharmacological and Pharmacokinetic Studies of Anti-diabetic Tropolonato-Zn(II) Complexes with Zn(S(2)O(2)) Coordination Mode
News

Pharmacological and Pharmacokinetic Studies of Anti-diabetic Tropolonato-Zn(II) Complexes with Zn(S(2)O(2)) Coordination Mode

Pharmacological and Pharmacokinetic Studies of Anti-diabetic Tropolonato-Zn(II) Complexes with Zn(S(2)O(2)) Coordination Mode
News

Pharmacological and Pharmacokinetic Studies of Anti-diabetic Tropolonato-Zn(II) Complexes with Zn(S(2)O(2)) Coordination Mode

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Pharmacological and Pharmacokinetic Studies of Anti-diabetic Tropolonato-Zn(II) Complexes with Zn(S(2)O(2)) Coordination Mode"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Abstract
Zn(II) complexes are expected to be useful in the treatment of diabetes mellitus because of the hypoglycemic effect produced by its insulin-mimetic activity. Previous reports indicated that Zn(II) complexes with coordinating sulfur exhibit higher insulin-mimetic activity. In this study, we investigated the pharmacological and pharmacokinetic differences between Zn(O(4)) and Zn(S(2)O(2)) coordination modes of tropolonato-Zn(II) complexes with insulin-mimetic activity. Among the tropolonato-Zn(II) complexes with various coordination modes, di(2-mercaptotropolonato)zinc(II) (ZT2) with the Zn(S(2)O(2)) coordination mode was found to exhibit the highest in vitro insulin-mimetic activity with respect to inhibition of free fatty acid (FFA) release and enhancement of glucose uptake in isolated rat adipocytes treated with adrenaline. On comparing investigations of the antidiabetic effect in vivo, ZT2 was found to exhibit potent hypoglycemic activity and improve insulin resistance in type 2 diabetic KKA(y) mice at a low orally administered daily dose. Di(tropolonato)zinc(II) (ZT1), which has the Zn(O(4)) coordination mode, had a lesser effect at the same dose. In a pharmacokinetic analysis based on the (65)Zn tracer method, ZT2 was found to be absorbed at a significantly slower rate with a longer half-life than was ZT1. These results suggest that the potent hypoglycemic activity of ZT2 might be attributed to its long half-life.

The article is published online in Chemical and Pharmaceutical Bulletin and is free to access.

Advertisement